Most licensed vaccines, including the current COVID-19 vaccines, are liquid formulations that need to be stored and transported in a refrigerated or frozen state, a severe problem for widespread distribution.
This project sought to address some of the limitations in vaccination logistics, namely the relatively short shelf life of many vaccines and the need for a cold chain.
This project will facilitate the development of stable vaccine candidates that do not require a cold chain, allowing them to be quickly, inexpensively, and easily distributed in future coronavirus outbreak, rapidly getting the vaccine to those in need.
Login to the NIIMBL member portal to access more, including:
Not yet a member? Learn more about which level of NIIMBL membership is right for you and your organization.
Fraunhofer USA